已核实 DOI PubMed 相关产品: 31

A regular Chlorella mannogalactan and its sulfated derivative as a promising anticoagulant: Structural characterization and anticoagulant activity

Journal 2023 · IF 11.2 · 发表于 2023 年 4 月 28 日
作者: Hao Tang,Jinwen Huang,Qingxia Yuan,Kunling Lv,Haiqiong Ma,Tingting Li,Yonghong Liu,Shunli Mi,Longyan Zhao
阅读全文 在 PubMed 查看

摘要

Chlorella is one of the most widely cultivated species of microalgae and has been consumed as a “green healthy food”. In this study, a novel polysaccharide (CPP-1) was isolated from Chlorella pyrenoidosa , structurally analyzed, and sulfated as a promising anticoagulant . Structural analyses by chemical and instrumental methods such as monosaccharide composition , methylation-GC–MS and 1D/2D NMR spectroscopy analysis revealed that CPP-1 had a molecular weight of ~13.6 kDa, and mainly consisted of d -mannopyranose ( d -Man p ), 3- O -methylated d -Man p (3- O -Me- d -Man p ), and d -galactopyranose ( d -Gal p ). The molar ratio of d -Man p and d -Gal p was 1.0:2.3. CPP-1 consisted of a (1→6)-linked β- d -Gal p backbone substituted at C-3 by the d -Man p and 3- O -Me- d -Man p residues in a molar ratio of 1:1, which was a regular mannogalactan. The sulfated Chlorella mannogalactan (SCM) with sulfated group content of 40.2 % equivalent to that of unfractionated heparin was prepared and analyzed. NMR analysis confirmed its structure, indicating that most free hydroxyl groups in the side chains and partial hydroxyl groups in the backbone were sulfated. Anticoagulant activity assays indicated that SCM exhibited strong anticoagulant activity by inhibiting intrinsic tenase (FXase) with IC 50 of 13.65 ng/mL, which may be a safer anticoagulant as an alternative to heparin-like drugs.

本研究中使用的阿拉丁产品

31 款产品在本文中被引用